Cyclodextrin for use in the treatment and prevention of late phase bronchoconstriction in allergen-induced asthma

摘要

An inhalable cyclodextrin for use in the treatment and prevention of late phase bronchoconstriction in allergen-induced asthma is disclosed. Further disclosed is the use of a cyclodextrin in the treatment and prevention by inhalation of late phase bronchoconstriction in allergen-induced asthma.